FDA Inspection
AXXELENT PHARMA SCIENCE PRIVATE LIMITEDAXXELENT PHARMA SCIENCE PRIVATE LIMITED – FDA Inspection, Apr 17, 2026
Record Details
This FDA Inspection record concerns AXXELENT PHARMA SCIENCE PRIVATE LIMITED, with an inspection on April 17, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 03411e18-d0ba-41bd-966b-1cec1125b678
Inspection Facts
- Inspection number
- 1315106
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of AXXELENT PHARMA SCIENCE PRIVATE LIMITED
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | Not classified | Office of Inspections and Investigations | |
| June 21, 2024 | Not classified | Office of Inspections and Investigations |
Other documents for AXXELENT PHARMA SCIENCE PRIVATE LIMITED
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.